title: Secondary cell wall polysaccharides of Bacillus anthracis are antigens that contain specific epitopes which cross-react with three pathogenic Bacillus cereus strains that caused severe disease, and other epitopes common to all the Bacillus cereus strains tested.
abstract: The immunoreactivities of hydrogen fluoride (HF)-released cell wall polysaccharides (HF-PSs) from selected Bacillus anthracis and Bacillus cereus strains were compared using antisera against live and killed B. anthracis spores. These antisera bound to the HF-PSs from B. anthracis and from three clinical B. cereus isolates (G9241, 03BB87, and 03BB102) obtained from cases of severe or fatal human pneumonia but did not bind to the HF-PSs from the closely related B. cereus ATCC 10987 or from B. cereus type strain ATCC 14579. Antiserum against a keyhole limpet hemocyanin conjugate of the B. anthracis HF-PS (HF-PS-KLH) also bound to HF-PSs and cell walls from B. anthracis and the three clinical B. cereus isolates, and B. anthracis spores. These results indicate that the B. anthracis HF-PS is an antigen in both B. anthracis cell walls and spores, and that it shares cross-reactive, and possibly pathogenicity-related, epitopes with three clinical B. cereus isolates that caused severe disease. The anti-HF-PS-KLH antiserum cross-reacted with the bovine serum albumin (BSA)-conjugates of all B. anthracis and all B. cereus HF-PSs tested, including those from nonclinical B. cereus ATCC 10987 and ATCC 14579 strains. Finally, the serum of vaccinated (anthrax vaccine adsorbed (AVA)) Rhesus macaques that survived inhalation anthrax contained IgG antibodies that bound the B. anthracis HF-PS-KLH conjugate. These data indicate that HF-PSs from the cell walls of the bacilli tested here are (i) antigens that contain (ii) a potentially virulence-associated carbohydrate antigen motif, and (iii) another antigenic determinant that is common to B. cereus strains.
authors.affiliation: Complex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA.
authors.forename: Christine
authors.initials: C
authors.lastname: Leoff
authors.forename: Elke
authors.initials: E
authors.lastname: Saile
authors.forename: Jana
authors.initials: J
authors.lastname: Rauvolfova
authors.forename: Conrad P
authors.initials: CP
authors.lastname: Quinn
authors.forename: Alex R
authors.initials: AR
authors.lastname: Hoffmaster
authors.forename: Wei
authors.initials: W
authors.lastname: Zhong
authors.forename: Alok S
authors.initials: AS
authors.lastname: Mehta
authors.forename: Geert-Jan
authors.initials: GJ
authors.lastname: Boons
authors.forename: Russell W
authors.initials: RW
authors.lastname: Carlson
authors.forename: Elmar L
authors.initials: EL
authors.lastname: Kannenberg
mesh_terms: D000818:Animals; D022122:Anthrax Vaccines / Q000276:immunology; D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology; D001408:Bacillus anthracis / Q000276:immunology*; D001409:Bacillus cereus / Q000276:immunology* / Q000472:pathogenicity*; D002240:Carbohydrate Sequence; D002473:Cell Wall / Q000276:immunology*; D003429:Cross Reactions; D000939:Epitopes / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D008253:Macaca mulatta; D008969:Molecular Sequence Data; D011135:Polysaccharides, Bacterial / Q000737:chemistry / Q000276:immunology*; D044967:Serum / Q000276:immunology
chemical_list: D022122:Anthrax Vaccines; D000907:Antibodies, Bacterial; D000939:Epitopes; D007074:Immunoglobulin G; D011135:Polysaccharides, Bacterial